GlassScriptPhysician profile
Ann M Corsi
NPI 1568418630
$4,321.65
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $494 · 2020: $193 · 2021: $968 · 2022: $1,138 · 2023: $1,107 · 2024: $421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,523 · Education: $5.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,522.67 |
| Education | $5.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,141.88 | 2019-2024 | Rinvoq, Humira |
| Amgen INC. | $817.55 | 2019-2024 | Enbrel, Evenity, Otezla |
| Lilly USA, LLC | $569.85 | 2019-2023 | Taltz, Olumiant |
| Glaxosmithkline, LLC. | $334.55 | 2020-2023 | Benlysta |
| Pfizer INC. | $304.45 | 2020-2024 | |
| Novartis Pharmaceuticals Corporation | $270.10 | 2019-2024 | |
| Fresenius Kabi USA, LLC | $148.64 | 2023-2024 | Idacio |
| E.R. Squibb & Sons, L.L.C. | $134.74 | 2019-2021 | |
| Genentech USA, INC. | $134.64 | 2019-2022 | |
| Ucb, INC. | $99.81 | 2021-2023 | Cimzia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.05 | 2023-2024 | Ofev, Cyltezo |
| Janssen Biotech, INC. | $84.17 | 2022-2023 | Tremfya |
| Radius Health, INC. | $75.13 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $28.38 | 2022 | |
| Mallinckrodt Hospital Products INC. | $22.58 | 2023 | Acthar |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $17.79 | 2023 | |
| Octapharma USA, INC. | $16.24 | 2022 | |
| Alexion Pharmaceuticals, INC. | $16.14 | 2024 | Strensiq |
| Sobi, INC | $15.96 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Corsi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.